[NuraN]

KAYNAKLAR
1. Pivnick EK, Riccardi VM. The neurofibromatosis. In: Freedberg IM, Eisen AZ,
Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB eds. Dermatology in
General Medicine. 5th ed. New York: McGraw-Hill 1999: 2152-8.
2. Neurofibromatosis. Conference Statement. National Institues of Health
Consensus Development Conference. Arch Neurol 1988; 45: 575-8.
3. Harper JI. Familial multible tumour syndrome. In: Champion RH, Burton JL,
Burns DA, Breathnach SM eds. Textbook of Dermatology. 6th ed. Oxford:
Blackwell Science Ltd 1998; 378-84.
4. Lazaro C, Gaona A, Ainsworth P, Tenconi R, Vidaud D, Kruyer H, Ars E,
Volpini V, Estivill X. Sex differences in mutational rate and mutational
mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet
1996; 98: 696-9.
5. McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R,
Kingston H, Super M, Harris R, Evans DG. A clinical study of type 1
neurofibromatosis in north west England. J Med Genet 1999; 36: 197-203.
6. Landau M, Krafchik BR. The diagnostic value of cafe-au-lait macules. J Am Acad
Dermatol 1999; 40: 877-90.
7. Arnsmeier SL, Riccardi VM, Paller AS. Familial multible cafe au lait spots. Arch
Dermatol 1994; 130: 1425-6.
8. Riccardi VM. Mast cell stabilization to decrease neurofibroma growth. Preliminary
experience with ketotifen. Arch Dermatol 1987; 123: 1011-6.
9. North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, de Silva
M. Specific learning disability in children with neurofibromatosis type 1:
significance of MRI abnormalities. Neurol 1994; 44: 878-83.
10. Hofman KJ, Boehm CD. Familial neurofibromatosis type 1: clinical experience
with DNA testing. J Pediatr 1992; 120: 394-8.
11. Elyakim S, Lerer I, Zlotogora J, Sagi M, Gelman-Kohan Z, Merin S, Abeliovich
D. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a
diagnostic tool. Am J Med Genet 1994; 53: 325-34.
Yazışma Adresi:
Dr. Başak Kandi
İnönü Üniversitesi Tıp Fakültesi
Dermatoloji AD
__________________